Lutris Pharma
PrivateLast Round
VC Round
Jan 28, 2025
Total Funding Raised
$5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Lutris Pharma is a clinical-stage biopharmaceutical company that develops novel topical therapies to mitigate the side effects of anti-cancer treatments such as EGFR inhibitors and radiation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lutris Pharma Comparables
Compare Lutris Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hoth Therapeutics Inc | 84% | |
| VasoDynamics Ltd | 81% | |
| Alys Pharmaceuticals | 81% | |
Lutris Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jan 28, 2025 | ||||
| Grant | Oct 24, 2022 | ||||
| VC Round | Jan 1, 2020 | ||||
| Seed | May 1, 2016 |
Lutris Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pontifax Venture Capital | VC Round, Seed |
| aMoon | VC Round |
| California Institute for Regenerative Medicine | Grant |
| Peregrine Ventures | VC Round |
| Columbus Venture Partners | VC Round |
| Arkin Capital | VC Round, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 12, 2026
Monthly visitors increased 118% MoM.
- Jul 7, 2025
Presented data at the ESMO Gastrointestinal Cancers Congress 2025.
Lutris Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Lutris Pharma's valuation, stock price, and market status.